Spots Global Cancer Trial Database for personalized

Every month we try and update this database with for personalized cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
A Study of the Efficacy and Safety of RO7198457 in Combination With Atezolizumab Versus Atezolizumab Alone Following Adjuvant Platinum-Doublet Chemotherapy in Participants Who Are ctDNA Positive After Surgical Resection of Stage II-III Non-Small Cell Lung Cancer	NCT04267237	Non-small Cell ...	Atezolizumab RO7198457	18 Years -	Hoffmann-La Roche
A Study of the Efficacy and Safety of RO7198457 in Combination With Atezolizumab Versus Atezolizumab Alone Following Adjuvant Platinum-Doublet Chemotherapy in Participants Who Are ctDNA Positive After Surgical Resection of Stage II-III Non-Small Cell Lung Cancer	NCT04267237	Non-small Cell ...	Atezolizumab RO7198457	18 Years -	Hoffmann-La Roche
Personalized PRRT of Neuroendocrine Tumors	NCT02754297	Neuroendocrine ... Carcinoid Tumor Carcinoma, Neur...	177Lu-Octreotat...	18 Years -	CHU de Quebec-Universite Laval
Exercise in Extended Oncogene Addicted Lung Cancer in Active Treatment	NCT05306652	Non-Small Cell ...	Supervised phys... Unsupervised ph...	18 Years -	AUSL Romagna Rimini
Drug Sensitivity Screening for Gastrointestinal Cancer	NCT04298489	Gastrointestina...	Personalized dr...	18 Years - 70 Years	Peking University Cancer Hospital & Institute
Drug Sensitivity Screening for Gastrointestinal Cancer	NCT04298489	Gastrointestina...	Personalized dr...	18 Years - 70 Years	Peking University Cancer Hospital & Institute
Pioneering Advances in Care and Education (PACE)	NCT03397160	Decision Suppor... Prostate Cancer	Decision Suppor...	18 Years -	University of California, San Francisco
Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine	NCT03633110	Cutaneous Melan... Non-small Cell ... Squamous Cell C... Urothelial Carc... Renal Cell Carc...	GEN-009 Adjuvan... Nivolumab Pembrolizumab	18 Years -	Genocea Biosciences, Inc.
A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy	NCT05896371	Cancer Prostate Cancer Metastatic Canc... Metastatic Pros...	177Lu-PSMA-I&T ... 177Lu-PSMA-I&T ...	18 Years -	CHU de Quebec-Universite Laval
A Study Combining Personalized Neoantigen-based Dendritic Cell Vaccine With Microwave Ablation for the Treatment of Hepatocellular Carcinoma	NCT03674073	Hepatocellular ... Liver Cancer, A...	Neoantigen Vacc... Microwave Ablat...	18 Years -	Chinese PLA General Hospital
Decision Support Tools for Men With Prostate Cancer- Clinical & Lifestyle Model	NCT02451345	Prostate Cancer	Personalized ri...	18 Years -	University of California, San Francisco
TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy	NCT04596033	Melanoma Non-small Cell ... Squamous Cell C... Urothelial Carc... Renal Cell Carc... Small-cell Lung... Cutaneous Squam... Anal Squamous C... Merkel Cell Car...	GEN-011 IL-2 Fludarabine Cyclophosphamid...	18 Years -	Genocea Biosciences, Inc.
A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors	NCT03289962	Melanoma Non-Small Cell ... Bladder Cancer Colorectal Canc... Triple Negative... Renal Cancer Head and Neck C... Other Solid Can...	Autogene cevume... Atezolizumab	18 Years -	Genentech, Inc.
Assessment of Feasibility and Acceptability of Personalized Breast Cancer Screening	NCT03791008	Breast Cancer	Risk based scre...	40 Years - 50 Years	Institut de Recerca Biomèdica de Lleida

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: